Shandong Xinhua Pharmaceutical Company Limited will convene its board of directors at 9:30 a.m. on 25 August 2026 in the company’s conference room at No. 1 Lutai Avenue, Hi-tech District, Zibo, Shandong, China.
The primary agenda is to review and approve the unaudited interim financial results of the company and its subsidiaries for the six months ended 30 June 2026. The board may also address other business matters during the session.
The board currently consists of Executive Directors He Tongqing (Chairman), Xu Wenhui and Hou Ning; Independent Non-executive Directors Pan Guangcheng, Zhu Jianwei, Ling Peixue and Cheung Ching Ching, Daisy; and Non-executive Director Zhang Chengyong.
The notice was issued by Chairman He Tongqing on 11 August 2026 in Zibo, Shandong.
Comments